MorphoSys and Chemicon International Enter into Worldwide Licensing Agreement for Research Antibodies
January 10, 2006 02:08 ET
|
MorphoSys AG
MARTINSRIED, Germany, Jan. 10, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) and Chemicon International, Inc., a subsidiary of Serologicals Corporation (Nasdaq:SERO)...
Telenor strengthens in Asia and Europe - new Group Management members appointed
January 10, 2006 02:08 ET
|
Telenor
Telenor is now establishing Asia and Eastern/Central Europe as separate areas of responsibility, with dedicated Executive Vice Presidents, as Telenor has previously done with its Nordic operations....
Nokia and Kyocera resolve patent dispute
January 10, 2006 02:00 ET
|
Nokia Oyj
Helsinki, Finland / Kyoto, Japan - Kyocera Corporation, along with its subsidiary, Kyocera Wireless Corp., and Nokia Corporation, along with its subsidiary Nokia Inc., today announced that they have...
MorphoSys Establishes American Depository Receipt Level One Program in USA
January 10, 2006 01:54 ET
|
MorphoSys AG
MARTINSRIED, Germany, Jan. 10, 2006 (PRIMEZONE) -- Morphosys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) today announced the launch of a sponsored ADR (American Depository Receipt) Program...
Artificial Life, Inc. Enters China Mobile Phone Market
January 10, 2006 01:42 ET
|
Artificial Life, Inc.
HONG KONG, Jan. 10, 2006 (PRIMEZONE) -- Hong Kong based Artificial Life, Inc. (Pink Sheets:ALIF), a leading provider of award winning mobile technology and applications, today announced its intention...
Novartis beschliesst, kein Angebot zur Akquisition von Berna Biotech zu unterbreiten
January 10, 2006 01:30 ET
|
Novartis Pharma AG
Basel, 10. Januar, 2006 - Nach Abschluss der Unternehmensprüfung und einer Beurteilung der potenziellen Vorteile und Risiken einer Akquisition hat Novartis beschlossen, kein Angebot für die Berna...
Novartis decides not to make offer to acquire Berna Biotech
January 10, 2006 01:30 ET
|
Novartis Pharma AG
Basel, January 10, 2006 - After completion of due diligence and an assessment of the potential benefits and risks of an acquisition, Novartis has decided not to make an offer for Berna Biotech...
Novartis décide de ne pas faire d'offre sur Berna Biotech
January 10, 2006 01:30 ET
|
Novartis Pharma AG
Bâle, le 10 janvier 2006 - Après l'examen des comptes et l'évaluation de l'intérêt et des risques que l'acquisition de la société de vaccins suisse pourrait représenter, Novartis a pris la décision de...
Maui General Store CEO to Cancel His Sale of Stock Under Rule 144
January 10, 2006 01:00 ET
|
China Digital Animation Development, Inc.
HANA, Hawaii, Jan. 10, 2006 (PRIMEZONE) -- Maui General Store CEO Richard Miller announced that he was cancelling his sale of Maui General Store shares under Rule 144. Mr. Miller feels that the...
IElement Corporation Closes $1.579 Million Private Placement
January 09, 2006 22:22 ET
|
IElement Corporation
DALLAS, Jan. 9, 2006 (PRIMEZONE) -- IElement Corporation (OTCBB:IELM) (Frankfurt:SZQ1), a nationwide provider of advanced communications services and Voice over Internet Protocol (VoIP) solutions,...
- January 08, 2025 13:15 ET Lieutenant Colonel Jennifer Pritzker Named as 2024 Philanthropist of the Year for Best in Biz Awards
- January 08, 2025 12:57 ET X-tosis to Present at Seed Showcase 2025 Alongside the J.P. Morgan Annual Healthcare Conference